Egg Intervention During Pregnancy in Indonesia

  • End date
    Mar 24, 2024
  • participants needed
  • sponsor
    SEAMEO Regional Centre for Food and Nutrition
Updated on 24 March 2021


The study consists of two arms: 1) intervention group using eggs as supplementary food given from 2nd trimester of pregnancy to birth, and 2) observational group of pregnant mothers. it aims to assess the effectiveness of improving dietary quality during pregnancy on the epigenetic and stunting related outcomes (growth and development) in infants, who will be followed up until 24 months old


The study aims to assess the impact of improving dietary quality during pregnancy on the epigenetic and stunting related outcomes in infants. The open-label intervention study would be conducted alongside the observational study in the same study setting by recruitment of additional number (n=153) of pregnant women. Thus, a total of 653 pregnant women would be enrolled in the study; 153 women would be randomized to intervention arm and 500 to the control arm who would form an observational cohort of women and newborns as described above. The intervention group women will be provided one egg three times per week from recruitment (2nd trimester) until term. The control group women will receive standard intervention in the form of Ante Natal Care from village midwives or Public Health Centre (IFA tablet, calcium tablet, nutrition counselling).

Condition Weight Gain, Shigellosis, Salmonellosis, Birth Weight, VITAMIN B12 DEFICIENCY, Vitamin A Deficiency, Escherichia coli Infection, Folic Acid Deficiency, Child Development, Salmonella, Protozoal disease, Vitamin Deficiency, Vitamin Deficiency, Iron deficiency anemia, Iron Deficiency, Zinc Deficiency, Mineral Deficiency, anemia, iron deficiency, shigella infections, Birth Length, Amino Acid Deficiency, Fatty Acid Deficiency, Parasite Infestation
Treatment Egg intervention
Clinical Study IdentifierNCT04694235
SponsorSEAMEO Regional Centre for Food and Nutrition
Last Modified on24 March 2021


Yes No Not Sure

Inclusion Criteria

Woman is between 16 and 20 weeks of pregnancy based on the date of the first day of her last menstrual period
She is 18-40 years of age
She is planning to remain in the study area over the next 30 months
She is of Sasak ethnicity

Exclusion Criteria

She is expecting multiple births
She has a known egg allergy
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note